EPAM Systems (EPAM): Evaluating Valuation After AI/Run Transform Launch and New Share Buyback Plan

EPAM Systems (EPAM) has rolled out its new AI/Run Transform Playbook, an offering that targets enterprise AI transformation through integrated consulting and specialized tools. In addition, its Board has approved a substantial share buyback plan, adding another layer of interest for investors.

See our latest analysis for EPAM Systems.

EPAM’s announcement of the AI/Run Transform Playbook and the fresh share repurchase plan comes on the heels of a volatile year, with recent headlines giving the stock some momentum. Last week’s 12% share price return stood out after a tough year to date, but the longer-term total shareholder return remains deeply negative, down over 53% across three years. Investors will be watching to see whether a renewed focus on innovation and capital return can turn sentiment and fortunes around.

If these moves pique your interest, it could be an ideal moment to broaden your investing horizons and discover fast growing stocks with high insider ownership

With the recent developments and shifting momentum, investors may be wondering if EPAM is trading below its true value or if the market is already reflecting expectations for a turnaround and future growth. Is there a buying opportunity, or is the optimism already reflected in the price?

Most Popular Narrative: 21% Undervalued

With the current share price well below the most-followed narrative's fair value, all eyes are on EPAM's prospects for profitable growth in a challenging market. The narrative's outlook factors in growth catalysts, margin expansion, and execution risks, making it a key benchmark for valuation debate.

The accelerating enterprise adoption of AI is driving a surge in demand for advanced data engineering, cloud migration, and platform modernization projects. These are areas where EPAM holds deep technical expertise, leading to increased revenue from larger and more complex client engagements. EPAM's strategic investments in AI-native services, proprietary platforms (such as DIAL and AI/RUN), and upskilling of over 80% of its workforce have positioned it as a transformation partner for clients moving beyond pilot AI programs to large-scale deployments. This supports sustainable revenue growth and the potential for improved net margins as EPAM moves up the value chain.

Read the complete narrative.

Want to peek into the forecast that could rewrite EPAM's future? The narrative rests on a blend of bold growth rates and ambition for improved profit margins. Think demand surge, higher-value projects, and a play for industry leadership. Curious how these ingredients are mixed to reach that headline valuation? Unlock the hidden math and see which transformative forces drive the target price.

Result: Fair Value of $206.80 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, ongoing wage inflation and intensifying competition from larger tech rivals remain key risks that could compress margins and reduce long-term growth potential.

Find out about the key risks to this EPAM Systems narrative.

Build Your Own EPAM Systems Narrative

If you have a different perspective or prefer to dig into the numbers yourself, you can easily craft your own view in just a few minutes with Do it your way.

A great starting point for your EPAM Systems research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.

Looking for More Smart Investing Opportunities?

There’s a world of high-potential stocks beyond EPAM, and the right screener can open doors to strategies you may be missing. Don’t let another opportunity slip past. Put these tailored ideas to work and shape your portfolio with confidence.

• Unlock fresh value plays by starting with these 875 undervalued stocks based on cash flows, where solid fundamentals and attractive pricing could point to your portfolio’s next strong performer.
• Capitalize on the rising healthcare tech trend through these 34 healthcare AI stocks, connecting you with companies pioneering medical breakthroughs powered by artificial intelligence.
• Accelerate your search for passive income. Select these 19 dividend stocks with yields > 3% to target stocks offering higher yields and robust dividend performance in one streamlined place.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com